Stefan Weber is Vice President in AstraZeneca, leading the Global Policy, Advocacy and Health Equity team, whose mission is to advance equitable health outcomes globally in close partnership with Governments, patients and stakeholders across the healthcare sector. Stefan and the team lead enterprise-wide programmes that advance equitable access to screening, early detection and treatment across AstraZeneca’s therapy areas, as well as initiatives that strengthen health system resilience and sustainability in both lower- and higher income markets.

Before joining AstraZeneca in 2020, Stefan spent his previous 15 years with Roche, Novartis and Amgen – where he held roles in marketing, market access, pricing, and various roles of increasing responsibility in public policy. Stefan lived and worked across a variety of markets, starting his career in Argentina and Brazil (covering Latin America), then moving to roles which covered Asia, the Middle-East and parts of Africa, later focussing on Europe and for the majority of the last eight years has held roles with a global scope.
Stefan’s academic background is in business administration and economics (Lic.oec.HSG, St. Gallen, 2005) and in global health policy (MSc, LSHTM London, 2016).

He currently lives in Switzerland with his wife and their two daughters. Besides his family and mission in healthcare, Stefan is passionate about disruptive technologies, sports, travel and the perfect BBQ."

Ashish Koshy holds the positions of Group Chief Operating Officer at M42, a global tech-enabled health powerhouse, and Chairman of the Board at Malaffi, the Abu Dhabi Health Information Exchange. With an entrepreneurial spirit, he excels at transforming challenges into viable business propositions across diverse sectors, from banking to telecom and healthcare. His leadership has propelled G42 Healthcare from startup status to a regional healthcare leader, lauded for pioneering initiatives spanning diagnostics, digital health, and more.

He has been instrumental in the merger with Mubadala Health which has now resulted in the creation of M42, an integrated healthcare powerhouse company with more than 20,000 employees and more than 450 facilities in 26 countries. He envisions an AI-powered ecosystem to tackle present and future challenges through public-private partnerships, driving impactful national programs and partnerships. Forbes has recognized his leadership, naming him a Top 100 Healthcare Leader for fostering innovation and growth. Prior to G42, Ashish held notable roles at Reliance Jio and Ooredoo, holding an MBA and MSc from prestigious institutions.

Abbes Seqqat currently serves as President of RAIN, the pioneering voice AI company behind "ORVA," the first-ever operating room voice assistant. With a rich background in driving innovation and business growth, Abbes has established himself as a visionary in the intersection of technology and healthcare.

Prior to his current role, Abbes held leadership positions at Sensetime, where he spearheaded business and growth initiatives across the Middle East and Africa (MEA) region. His strategic insights and leadership were instrumental in positioning Sensetime as a key player in the AI landscape, particularly within the medical imaging space.

Before his tenure at Sensetime, Abbes served as a trusted advisor on digital transformation and disruption to leading conglomerates in the region during his tenure at Oracle, IBM Watson Health and Accenture. His expertise in leveraging cutting-edge technologies has enabled organizations to revolutionize their operations and enhance patient care delivery.

His thought leadership and strategic guidance continue to shape the future of healthcare, driving innovation and improving outcomes for patients globally. With a proven track record of success and passion for leveraging technology for the greater good, Abbes remains at the forefront of the AI health tech industry, leading RAIN towards new heights of innovation and impact.